Navigation Links
Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026
Date:11/16/2016

NEW YORK, Nov. 16, 2016 /PRNewswire/ -- Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Rheumatoid Arthritis in 17 Major Markets

Rheumatoid arthritis (RA) is classified as an autoimmune disease and occurs when the immune system attacks the synovium (membranes surrounding joints). The inflammation resulting from the attack causes thickening of the synovium, which eventually destroys the cartilage and bone within the joint. The tendons and ligaments holding the joint together weaken and stretch, resulting in gradual loss of joint shape and alignment.

Prevalence of RA has been rumoured to be in decline over the past 20-30 years, although there is nothing concrete in the literature to substantiate if this is actually the case.
This report provides the current prevalent population for Rheumatoid Arthritis across 17 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, NL, Denmark, Norway, Greece, Turkey, Brazil, Mexico, Argentina, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Rheumatoid Arthritis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

The following are considered features or comorbid conditions associated with RA:
- Smoking
- Obesity
- Diabetes
- Metabolic syndrome
- Hypertension
- Extra-articular manifestations
- Erosive disease
- Cachexia (muscle wasting)

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy
- Able to quantify patient populations in the global Rheumatoid Arthritis market to target the development of future products, pricing strategies and launch plans.
- Gain further insight into the prevalence of the subdivided types of Rheumatoid Arthritis and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Provide a level of understanding on the impact from specific co-morbid conditions on Rheumatoid Arthritis's prevalent population.
- Identify sub-populations within Rheumatoid Arthritis which require treatment.
- Gain an understanding of the specific markets that have the largest number of Rheumatoid Arthritis patients.

Read the full report: http://www.reportlinker.com/p04208329-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/epiomic-epidemiology-series-rheumatoid-arthritis-forecast-in-17-major-markets-2016-2026-300364691.html


'/>"/>
SOURCE Reportlinker
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. EpiCast Report: Gram-Negative Bacterial Pneumonia - Epidemiology Forecast to 2022
2. EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023
3. Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers
4. EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2023
5. EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023
6. EpiCast Report: Diabetic Macular Edema - Epidemiology Forecast to 2023
7. EpiCast Report: Sepsis - Epidemiology Forecast to 2023
8. Mapi integrates Epidemiology, HEOR and Strategic Market Access into Real World Strategy and Analytics
9. Mapi intègre les services Epidemiology, HEOR (Health Economics Outcomes Research) et Strategic Market Access dans son département Real World Strategy and Analytics
10. 2015-2019 Global Tuberculosis Diagnostic Testing Market - Current scientific Views on the Tuberculosis Definition, Epidemiology and Etiology are Reviewed
11. VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)...  ValGenesis Inc., the global leader in Enterprise ... announce the appointment of Dr. Ajaz Hussain ... Directors and Chairman of Advisory Board beginning September ... to manage their entire validation lifecycle process electronically ... process. Furthermore, ValGenesis VLMS enables rigorous compliance, helps ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
Breaking Medicine News(10 mins):